TrialSite’s “Site Watch Leading” reports that Meridian Clinical Research won the 2020 Vaccine Industry Excellence (ViE) award for “Best Clinical Trial Site.” Meridian, the largest member of Platinum Research Network, reported that that network also won the award for “Best Clinical Trial Network.” The winners were announced at the virtual World Vaccine Congress. TrialSite shares a brief profile of Meridian clinical research.
These awards were decided by two rounds of voting and a final judgment by a scientific advisory board. Judges reviewed performance metrics, diversity of capabilities for vaccine trials, ongoing outcomes, and other factors to select a winner.
Comments from Founder
Nicole Osborn, Meridian’s founder and CEO, shared in their recent press release associated with the award, “It reaffirms the quality of our work our investigators and staff put forward every day, and the trust we’ve established with leading vaccine developers.” The founder emphasized when the COVID-19 pandemic response occurred, her team was ready with the right capabilities and reach required by vaccine developers and their CROs.
Earlier in the year, Mer...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).